Pijnenborg JMA - Search Results

1

Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.

Vrede SW, Kasius J, Bulten J, Teerenstra S, Huvila J, Colas E, Gil-Moreno A, Boll D, Vos MC, van Altena AM, Asberger J, Sweegers S, van Weelden WJ, van der Putten LJM, Amant F, Visser NCM, Snijders MPLM, Küsters-Vandevelde HVN, Kruitwagen R, Matias-Guiu X, Weinberger V, Reijnen C, Pijnenborg JMA. Vrede SW, et al. Among authors: pijnenborg jma. JAMA Netw Open. 2022 Dec 1;5(12):e2247372. doi: 10.1001/jamanetworkopen.2022.47372. JAMA Netw Open. 2022. PMID: 36525269 Free PMC article.

2

TP53 overexpression in recurrent endometrial carcinoma.

Pijnenborg JM, van de Broek L, Dam de Veen GC, Roemen GM, de Haan J, van Engeland M, Voncken JW, Groothuis PG. Pijnenborg JM, et al. Gynecol Oncol. 2006 Feb;100(2):397-404. doi: 10.1016/j.ygyno.2005.09.056. Epub 2005 Nov 4. Gynecol Oncol. 2006. PMID: 16271749

3

RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer.

Pijnenborg JM, Dam-de Veen GC, Kisters N, Delvoux B, van Engeland M, Herman JG, Groothuis PG. Pijnenborg JM, et al. Ann Oncol. 2007 Mar;18(3):491-7. doi: 10.1093/annonc/mdl455. Epub 2006 Dec 14. Ann Oncol. 2007. PMID: 17170014 Free article.

4

Hypoxia contributes to development of recurrent endometrial carcinoma.

Pijnenborg JM, Wijnakker M, Hagelstein J, Delvoux B, Groothuis PG. Pijnenborg JM, et al. Int J Gynecol Cancer. 2007 Jul-Aug;17(4):897-904. doi: 10.1111/j.1525-1438.2007.00893.x. Epub 2007 Mar 13. Int J Gynecol Cancer. 2007. PMID: 17359291

5

Comment on: Recurrence rate in vulvar carcinoma in relation to pathological margin distance [Groenen SMA, Timmers PJ, Burger CW. Int J Gynecol Cancer. 2010;20:869-873].

Pijnenborg JM, Boll D, Hermans RH. Pijnenborg JM, et al. Int J Gynecol Cancer. 2011 Jul;21(5):794. doi: 10.1097/IGC.0b013e31821bc638. Int J Gynecol Cancer. 2011. PMID: 21697677 No abstract available.

6

van de Poll-Franse LV, Pijnenborg JM, Boll D, Vos MC, van den Berg H, Lybeert ML, de Winter K, Kruitwagen RF. van de Poll-Franse LV, et al. Gynecol Oncol. 2012 Oct;127(1):153-60. doi: 10.1016/j.ygyno.2012.06.007. Epub 2012 Jun 13. Gynecol Oncol. 2012. PMID: 22704950 Clinical Trial.

7

Predicting the coexistence of an endometrial adenocarcinoma in the presence of atypical complex hyperplasia: immunohistochemical analysis of endometrial samples.

Robbe EJ, van Kuijk SM, de Boed EM, Smits LJ, van der Wurff AA, Kruitwagen RF, Pijnenborg JM. Robbe EJ, et al. Int J Gynecol Cancer. 2012 Sep;22(7):1264-72. doi: 10.1097/IGC.0b013e31826302a3. Int J Gynecol Cancer. 2012. PMID: 22872167

8

Preoperative identification of synchronous ovarian and endometrial cancers: the importance of appropriate workup.

Broeders FM, van der Wurff AA, Pijnenborg JM, Vos MC. Broeders FM, et al. Int J Gynecol Cancer. 2012 Oct;22(8):1325-31. doi: 10.1097/IGC.0b013e3182679119. Int J Gynecol Cancer. 2012. PMID: 22968517

9

Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.

Geels YP, Pijnenborg JM, van den Berg-van Erp SH, Bulten J, Visscher DW, Dowdy SC, Massuger LF. Geels YP, et al. Obstet Gynecol. 2012 Nov;120(5):1124-31. doi: 10.1097/aog.0b013e31825bc3b4. Obstet Gynecol. 2012. PMID: 23090531

10

The relationship of body mass index with quality of life among endometrial cancer survivors: a study from the population-based PROFILES registry.

Oldenburg CS, Boll D, Nicolaije KA, Vos MC, Pijnenborg JM, Coebergh JW, Beijer S, van de Poll-Franse LV, Ezendam NP. Oldenburg CS, et al. Gynecol Oncol. 2013 Apr;129(1):216-21. doi: 10.1016/j.ygyno.2012.12.041. Epub 2013 Jan 5. Gynecol Oncol. 2013. PMID: 23296262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters